A Novel Mutation of AMHR2 in Two Siblings with Persistent Müllerian Duct Syndrome

Persistent Müllerian Duct syndrome (PMDS) develops due to deficiency of anti-Müllerian hormone (AMH) or insensitivity of target organs to AMH in individuals with 46,XY karyotype. PMDS is characterized by normal male phenotype of external genitals, associated with persistence of Müllerian structures. This report includes the presentation of a 2.5 year old male patient due to bilateral undescended testis. His karyotype was 46,XY. The increase in testosterone following human chorionic gonadotropin stimulation test was normal. The patient was referred to our clinic after uterine, fallopian tube and vaginal remnants were recognized during the orchiopexy surgery. The family reported that the eight year old elder brother of the patient was operated on for right inguinal hernia and left undescended testis at the age of one year. A right transverse testicular ectopia was found in the elder brother. Both cases had normal AMH levels. AMHR2 gene was analyzed and a homozygous NM_020547.3:c.233-1G>A mutation was found that was not identified previously. In conclusion, we determined a novel mutation in the AMHR2 gene that was identified for the first time. This presented with different phenotypes in two siblings.

[1]  J. Picard,et al.  The Persistent Müllerian Duct Syndrome: An Update Based Upon a Personal Experience of 157 Cases , 2017, Sexual Development.

[2]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[3]  J. Hutson,et al.  Malformation syndromes associated with disorders of sex development , 2014, Nature Reviews Endocrinology.

[4]  R. Rey,et al.  Anti-Müllerian Hormone: A Valuable Addition to the Toolbox of the Pediatric Endocrinologist , 2013, International journal of endocrinology.

[5]  L. Patel,et al.  Persistent Müllerian duct syndrome: lessons learned from managing a series of eight patients over a 10‐year period and review of literature regarding malignant risk from the Müllerian remnants , 2012, BJU international.

[6]  M. Abduljabbar,et al.  Mutations of the AMH Type II Receptor in Two Extended Families with Persistent Müllerian Duct Syndrome: Lack of Phenotype/Genotype Correlation , 2012, Hormone Research in Paediatrics.

[7]  R. Rey,et al.  Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications. , 2006, Pediatric endocrinology reviews : PER.

[8]  R. Bussani,et al.  Bilateral testicular carcinoma in patient with the persistent müllerian duct syndrome. , 2002, The Journal of urology.

[9]  J. Picard,et al.  Persistence of Müllerian derivatives in males. , 1999, American journal of medical genetics.

[10]  D. Vandersteen,et al.  Surgical management of persistent müllerian duct syndrome. , 1997, Urology.

[11]  S. Imbeaud,et al.  A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome. , 1996, Human molecular genetics.

[12]  T. I. Farag.  Familial persistent müllerian duct syndrome in Kuwait and neighboring populations. , 1993, American journal of medical genetics.

[13]  P. Donahoe,et al.  Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells , 1986, Cell.

[14]  M. Mattei,et al.  Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19. , 1987, Cytogenetics and cell genetics.